Clinical Trial Update: The Safety and Efficacy of Cerebrolysin in Patients With Acute Ischemic Stroke [Phase 4]

View source ↗

Summary

Phase 4 trial update assessing safety and efficacy of Cerebrolysin in patients with acute ischemic stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Cerebrolysin

Snippet

Sponsor: Ever Neuro Pharma GmbH | Conditions: Ischemic Stroke | Phase 4 | Status: COMPLETED